{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T06:50:17Z","timestamp":1778482217877,"version":"3.51.4"},"reference-count":20,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["surgjournal.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Surgery"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1016\/j.surg.2018.03.030","type":"journal-article","created":{"date-parts":[[2018,11,8]],"date-time":"2018-11-08T17:43:23Z","timestamp":1541699003000},"page":"178-185","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["68Gallium-DOTATATE positron emission tomography\u2013computed tomography (PET CT) changes management in a majority of patients with neuroendocrine tumors"],"prefix":"10.1016","volume":"165","author":[{"given":"John F.","family":"Tierney","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cory","family":"Kosche","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erik","family":"Schadde","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amjad","family":"Ali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sumeet","family":"Virmani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sam G.","family":"Pappas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer","family":"Poirier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xavier M.","family":"Keutgen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.surg.2018.03.030_bib0001","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1002\/cncr.29099","article-title":"Exploring the rising incidence of neuroendocrine tumors: a population-based analysis of epidemiology, metastatic presentation, and outcomes","volume":"121","author":"Hallet","year":"2015","journal-title":"Cancer"},{"key":"10.1016\/j.surg.2018.03.030_bib0002","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1159\/000443167","article-title":"ENETS consensus guidelines update for the management of distant metastatic disease of intestinal, pancreatic, bronchial neuroendocrine neoplasms (NEN) and NEN of unknown primary site","volume":"103","author":"Pavel","year":"2016","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.surg.2018.03.030_bib0003","doi-asserted-by":"crossref","first-page":"111","DOI":"10.2217\/fon-2017-0393","article-title":"The utility of 68Ga-DOTATATE positron-emission tomography\/computed tomography in the diagnosis, management, follow-up and prognosis of neuroendocrine tumors","volume":"14","author":"Tirosh","year":"2018","journal-title":"Future Oncol Lond Engl"},{"key":"10.1016\/j.surg.2018.03.030_bib0004","first-page":"426","article-title":"The value of (68)Ga-DOTATATE PET\/CT in diagnosis and management of neuroendocrine tumors compared to current FDA approved imaging modalities: a review of literature","volume":"4","author":"Mojtahedi","year":"2014","journal-title":"Am J Nucl Med Mol Imaging"},{"key":"10.1016\/j.surg.2018.03.030_bib0005","doi-asserted-by":"crossref","first-page":"2447","DOI":"10.1002\/cncr.23469","article-title":"Functional imaging of neuroendocrine tumors with combined PET\/CT using 68Ga-DOTATATE (DOTA-DPhe1,Tyr3-octreotate) and 18F-FDG","volume":"112","author":"Kayani","year":"2008","journal-title":"Cancer"},{"key":"10.1016\/j.surg.2018.03.030_bib0006","first-page":"756","article-title":"The impact of somatostatin receptor-directed PET\/CT on the management of patients with neuroendocrine tumor: a systematic review and meta-analysis","volume":"58","author":"Barrio","year":"2017","journal-title":"J Nucl Med Off Publ Soc Nucl Med"},{"key":"10.1016\/j.surg.2018.03.030_bib0007","first-page":"708","article-title":"Safety and efficacy of 68Ga-DOTATATE PET\/CT for diagnosis, staging, and treatment management of neuroendocrine tumors","volume":"57","author":"Deppen","year":"2016","journal-title":"J Nucl Med Off Publ Soc Nucl Med"},{"key":"10.1016\/j.surg.2018.03.030_bib0008","first-page":"855","article-title":"Measured human dosimetry of 68Ga-DOTATATE","volume":"54","author":"Walker","year":"2013","journal-title":"J Nucl Med Off Publ Soc Nucl Med"},{"key":"10.1016\/j.surg.2018.03.030_bib0009","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1200\/JCO.2015.64.0987","article-title":"Prospective study of 68Ga-DOTATATE positron emission tomography\/computed tomography for detecting gastro-entero-pancreatic neuroendocrine tumors and unknown primary sites","volume":"34","author":"Sadowski","year":"2016","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"key":"10.1016\/j.surg.2018.03.030_bib0010","unstructured":"National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology. Neuroendocrine Tumors Version 3.2017 [Internet]. National Comprehensive Cancer Network; 2017. Available from: https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/neuroendocrine.pdf. Accessed: October 15, 2017."},{"key":"10.1016\/j.surg.2018.03.030_bib0011","unstructured":"R Core Team. Vienna, Austria: R Foundation for Statistical Computing; 2016. Available from: https:\/\/www.R-project.org\/. Accessed: October 15, 2017."},{"key":"10.1016\/j.surg.2018.03.030_bib0012","first-page":"34","article-title":"The impact of 68Ga-DOTATATE PET\/CT imaging on management of patients with neuroendocrine tumors: experience from a national referral center in the United Kingdom","volume":"57","author":"Skoura","year":"2016","journal-title":"J Nucl Med Off Publ Soc Nucl Med"},{"key":"10.1016\/j.surg.2018.03.030_bib0013","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1089\/thy.2016.0174","article-title":"The rate and clinical significance of incidental thyroid uptake as detected by Gallium-68 DOTATATE positron emission tomography\/computed tomography","volume":"26","author":"Nockel","year":"2016","journal-title":"Thyroid Off J Am Thyroid Assoc"},{"key":"10.1016\/j.surg.2018.03.030_bib0014","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1007\/s12149-013-0718-4","article-title":"Physiological and tumoral uptake of 68Ga-DOTATATE: standardized uptake values and challenges in interpretation","volume":"27","author":"Kuyumcu","year":"2013","journal-title":"Ann Nucl Med"},{"key":"10.1016\/j.surg.2018.03.030_bib0015","first-page":"1686","article-title":"The role of 68Ga-DOTATATE PET\/CT in suspected neuroendocrine tumors","volume":"53","author":"Haug","year":"2012","journal-title":"J Nucl Med Off Publ Soc Nucl Med"},{"key":"10.1016\/j.surg.2018.03.030_bib0016","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1007\/s00259-016-3357-x","article-title":"PET\/CT comparing (68)Ga-DOTATATE and other radiopharmaceuticals and in comparison with CT\/MRI for the localization of sporadic metastatic pheochromocytoma and paraganglioma","volume":"43","author":"Janssen","year":"2016","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.surg.2018.03.030_bib0017","doi-asserted-by":"crossref","first-page":"3888","DOI":"10.1158\/1078-0432.CCR-14-2751","article-title":"Superiority of [68Ga]-DOTATATE PET\/CT to other functional imaging modalities in the localization of SDHB-associated metastatic pheochromocytoma and paraganglioma","volume":"21","author":"Janssen","year":"2015","journal-title":"Clin Cancer Res Off J Am Assoc Cancer Res"},{"key":"10.1016\/j.surg.2018.03.030_bib0018","first-page":"22","article-title":"(68)Ga-DOTATATE and (18)F-FDG PET\/CT in paraganglioma and pheochromocytoma: utility, patterns and heterogeneity","volume":"16","author":"Chang","year":"2016","journal-title":"Cancer Imaging Off Publ Int Cancer Imaging Soc"},{"key":"10.1016\/j.surg.2018.03.030_bib0019","doi-asserted-by":"crossref","first-page":"66","DOI":"10.2967\/jnumed.117.202275","article-title":"Appropriate use criteria for somatostatin receptor PET imaging in neuroendocrine tumors","volume":"59","author":"Hope","year":"2018","journal-title":"J Nucl Med"},{"key":"10.1016\/j.surg.2018.03.030_bib0020","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1148\/radiol.13122501","article-title":"Neuroendocrine tumor recurrence: diagnosis with 68Ga-DOTATATE PET\/CT","volume":"270","author":"Haug","year":"2014","journal-title":"Radiology"}],"container-title":["Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039606018306238?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039606018306238?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,8]],"date-time":"2018-12-08T07:59:00Z","timestamp":1544255940000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0039606018306238"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":20,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,1]]}},"alternative-id":["S0039606018306238"],"URL":"https:\/\/doi.org\/10.1016\/j.surg.2018.03.030","relation":{},"ISSN":["0039-6060"],"issn-type":[{"value":"0039-6060","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"68Gallium-DOTATATE positron emission tomography\u2013computed tomography (PET CT) changes management in a majority of patients with neuroendocrine tumors","name":"articletitle","label":"Article Title"},{"value":"Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.surg.2018.03.030","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}